NBIX
$143.18+1.76%
as of close, Oct 2, 2026
☾ AH $143.18 +1.76%
Neurocrine Biosciences Inc.Stock · Health CareNasdaq Composite 0.03%Russell 1000 0.02%US Stock Market 0.02%Russell 3000 0.02%MSCI World 0.02%MSCI ACWI 0.02%
NBIX financial statements
The full income statement, balance sheet, and cash-flow statement for Neurocrine Biosciences Inc. (NBIX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 101.0M2024-09 101.2M2024-12 99.7M2025-03 99.0M2025-06 99.2M2025-09 99.7M2025-12 100.4M2026-03 100.5M2026-06 101.6M+0.7% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 2.86B+21.4% | 2.36B+24.8% | 1.89B+26.8% | 1.49B+31.3% | 1.13B+8.4% | |
| Cost of revenue | 52.1M+53.2% | 34.0M-14.4% | 39.7M+71.1% | 23.2M+62.2% | 14.3M+41.6% | |
| — | — | — | — | 1.03B+16.8% | ||
| Research & development | 1.02B+38.9% | 731M+29.4% | 565M+21.8% | 464M+41.4% | 328M+19.3% | |
| Selling, general & administrative | 1.16B+14.8% | 1.01B+13.5% | 888M+17.9% | 753M+29.0% | 583M+34.6% | |
| Amortization of intangibles | 4.10M+13.9% | 3.60M+2.9% | 3.50M+600.0% | 500K | 0.00 | |
| Operating income | 619M+8.5% | 571M+127.4% | 251M+0.8% | 249M+142.9% | 103M-37.1% | |
| Interest expense | — | — | 4.60M-35.2% | 7.10M-72.5% | 25.8M-21.3% | |
| Other non-operating income | 86.3M+202.1% | -84.5M-204.1% | 81.2M+331.3% | -35.1M-3090.9% | -1.10M+98.0% | |
| Gain (loss) on equity securities | -4.00M+89.2% | -37.1M-230.6% | 28.4M-7.8% | 30.8M+47.4% | 20.9M+218.1% | |
| Pre-tax income | 705M+45.1% | 486M+46.3% | 332M+55.3% | 214M+110.9% | 101M-5.0% | |
| Income tax | 227M+56.7% | 145M+75.6% | 82.4M+38.7% | 59.4M+403.4% | 11.8M+103.9% | |
| 479M+40.2% | 341M+36.7% | 250M+61.6% | 155M+72.4% | 89.6M-78.0% | ||
| Net income to common | 479M+40.2% | 341M+36.7% | 250M+61.6% | 155M+72.4% | 89.6M-78.0% | |
| $4.67+41.9% | $3.29+33.2% | $2.47+58.3% | $1.56+69.6% | $0.92-77.9% | ||
| EPS (basic) | $4.81+41.5% | $3.40+32.8% | $2.56+59.0% | $1.61+69.5% | $0.95-78.3% | |
| Weighted-avg shares (basic) | 99.5M-0.9% | 100M+2.8% | 97.7M+2.0% | 95.8M+1.3% | 94.6M+1.6% | |
| Weighted-avg shares (diluted) | 103M-1.2% | 104M+2.7% | 101M+2.1% | 98.9M+1.0% | 97.9M+0.1% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 2.52B+46.3% | 1.72B+7.3% | 1.61B+10.6% | 1.45B+49.4% | 973M-4.3% | ||
| Cash & equivalents | 713M+206.0% | 233M-7.2% | 251M-4.5% | 263M-22.9% | 341M+82.1% | |
| Short-term investments | — | — | — | — | 371M-39.6% | |
| Accounts receivable | 687M+43.4% | 479M+9.1% | 439M+25.5% | 350M+88.7% | 186M+18.1% | |
| Inventory | 69.0M+20.2% | 57.4M+49.9% | 38.3M+9.1% | 35.1M+15.1% | 30.5M+8.9% | |
| Prepaid expenses | 171M+252.0% | 48.5M | — | — | — | |
| Other current assets | 116M+82.1% | 63.6M-35.0% | 97.8M+23.6% | 79.1M+73.8% | 45.5M+51.2% | |
| 4.63B+24.5% | 3.72B+14.4% | 3.25B+37.3% | 2.37B+14.3% | 2.07B+19.5% | ||
| Property, plant & equipment | 89.8M+8.7% | 82.6M+16.7% | 70.8M+20.8% | 58.6M+0.0% | 58.6M+31.4% | |
| Operating lease right-of-use | 455M-10.6% | 509M+84.2% | 277M+217.8% | 87.0M-10.5% | 97.2M+17.4% | |
| Goodwill | 6.10M+7.0% | 5.70M-1.7% | 5.80M+7.4% | 5.40M | 0.00 | |
| Intangible assets | 4.70M-87.1% | 36.5M+2.8% | 35.5M-4.6% | 37.2M | 0.00 | |
| Long-term investments | — | — | — | 299M-46.6% | 561M+146.9% | |
| Deferred tax assets | 320M-34.1% | 486M+33.9% | 363M+18.5% | 306M-2.9% | 315M-1.3% | |
| Other non-current assets | 48.7M-6.3% | 52.0M+4.8% | 49.6M+98.4% | 25.0M+468.2% | 4.40M-31.3% | |
| 743M+46.4% | 508M-22.5% | 655M+21.8% | 538M+118.8% | 246M+31.8% | ||
| Accrued liabilities | 674M+46.1% | 462M+2.9% | 449M+29.1% | 348M+53.9% | 226M+33.8% | |
| Current lease liability | 56.0M+37.9% | 40.6M+26.9% | 32.0M+83.9% | 17.4M+5.5% | 16.5M+60.2% | |
| Other current liabilities | 69.1M+49.9% | 46.1M+28.4% | 35.9M+73.4% | 20.7M+3.5% | 20.0M+12.4% | |
| 1.38B+22.1% | 1.13B+10.8% | 1.02B+54.2% | 661M-5.4% | 699M+14.8% | ||
| Non-current lease liability | 415M-8.7% | 455M+76.2% | 258M+176.3% | 93.5M-11.2% | 105M+11.5% | |
| Operating lease liability (total) | 471M-4.9% | 496M+70.8% | 290M+161.8% | 111M-8.9% | 122M+16.3% | |
| Deferred tax liabilities | 0.00 | — | — | — | — | |
| Other non-current liabilities | 220M+32.2% | 166M+56.3% | 106M+257.9% | 29.7M+141.5% | 12.3M+26.8% | |
| 3.25B+25.6% | 2.59B+16.0% | 2.23B+30.7% | 1.71B+24.3% | 1.37B+22.0% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 100K+0.0% | 100K+0.0% | 100K+0.0% | 100K+0.0% | 100K+0.0% | |
| Additional paid-in capital | 2.79B+9.3% | 2.55B+7.2% | 2.38B+12.2% | 2.12B+5.5% | 2.01B+8.7% | |
| Retained earnings | 448M+1433.2% | 29.2M+118.6% | -157M+61.4% | -407M+36.0% | -636M+12.4% | |
| Accumulated other comprehensive income | 13.1M+125.9% | 5.80M-17.1% | 7.00M+188.6% | -7.90M-364.7% | -1.70M-194.4% | |
| Total liabilities & equity | 4.63B+24.5% | 3.72B+14.4% | 3.25B+37.3% | 2.37B+14.3% | 2.07B+19.5% | |
| Common shares issued | 100M+0.7% | 99.4M+0.7% | 98.7M+2.3% | 96.5M+1.7% | 94.9M+1.5% | |
| Common shares outstanding | 100M+0.7% | 99.4M+0.7% | 98.7M+2.3% | 96.5M+1.7% | 94.9M+1.5% | |
| Shares outstanding (cover) | 100M+0.7% | 99.7M+0.2% | 99.5M+3.0% | 96.6M+1.4% | 95.2M+1.4% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 783M+31.5% | 595M+52.7% | 390M+14.9% | 339M+32.3% | 257M+12.3% | ||
| Depreciation & amortization | 30.1M+11.1% | 27.1M+27.2% | 21.3M+36.5% | 15.6M+43.1% | 10.9M+26.7% | |
| Intangible amortization | 4.10M+13.9% | 3.60M+2.9% | 3.50M+600.0% | 500K | 0.00 | |
| Share-based compensation | 218M+11.5% | 196M+0.6% | 194M+12.2% | 173M+29.0% | 134M+34.2% | |
| Deferred income taxes | 164M+233.5% | -123M-102.6% | -60.7M-375.9% | 22.0M+300.0% | 5.50M+101.8% | |
| Change in receivables | 211M+428.9% | 39.8M-55.4% | 89.3M-44.9% | 162M+471.1% | 28.4M-6.9% | |
| Change in inventory | 15.3M-19.9% | 19.1M+453.7% | -5.40M-307.7% | 2.60M+4.0% | 2.50M-76.6% | |
| Other operating activities | 700K+600.0% | 100K-85.7% | 700K-56.3% | 1.60M+153.3% | -3.00M-181.1% | |
| -264M-108.5% | -127M+72.9% | -467M-163.7% | -177M-36.0% | -130M-3275.6% | ||
| Capital expenditure | 34.0M-11.0% | 38.2M+35.0% | 28.3M+71.5% | 16.5M-29.5% | 23.4M+114.7% | |
| Free cash flow | 749M+34.4% | 557M+54.1% | 362M+12.0% | 323M+38.5% | 233M+7.1% | |
| Acquisitions | 0.00 | 0.00 | 0.00-100.0% | 42.7M | 0.00 | |
| -38.3M+92.1% | -487M-845.3% | 65.3M+127.9% | -234M-955.1% | 27.4M+117.4% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 129M+6.0% | 122M+87.0% | 65.3M+46.1% | 44.7M+62.5% | 27.5M-5.5% | |
| Common stock repurchased | 168M-44.1% | 300M | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FX effect on cash | 0.00 | 0.00-100.0% | 300K+123.1% | -1.30M | 0.00 | |
| Net change in cash | 480M+2751.9% | -18.1M-56.0% | -11.6M+84.2% | -73.3M-147.7% | 154M+105.5% | |
| Interest paid | 0.00-100.0% | 1.60M-57.9% | 3.80M-42.4% | 6.60M-23.3% | 8.60M-25.9% | |
| Income taxes paid | 81.4M-62.6% | 218M+322.3% | 51.5M+257.6% | 14.4M+182.4% | 5.10M-66.7% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 14.2B+4.6% | 13.6B+5.1% | 12.9B+12.7% | 11.5B+41.6% | 8.11B-9.9% | |
| P/E | 29.7×-25.4% | 39.9×-41.2% | 67.8×-65.6% | 197.3×+117.9% | 90.5×+309.5% | |
| P/S | 5.0×-13.9% | 5.8×-20.4% | 7.3×-12.2% | 8.3×+15.5% | 7.2×-16.9% | |
| P/B | 4.4×-16.7% | 5.3×-18.7% | 6.5×-13.0% | 7.4×+25.9% | 5.9×-26.2% | |
| P/FCF | 19.0×-22.2% | 24.4×-27.4% | 33.7×-48.1% | 64.9×+86.4% | 34.8×-15.9% | |
| Earnings yield | 3.4%+34.1% | 2.5%+70.0% | 1.5%+191.1% | 0.51%-54.1% | 1.1%-75.6% | |
| FCF yield | 5.3%+28.5% | 4.1%+37.8% | 3.0%+92.8% | 1.5%-46.4% | 2.9%+18.9% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: NBIX’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all NBIX filings on SEC EDGAR → Not investment advice.